Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
KAZIA TO PRESENT FINAL DATA FROM PAXALISIB PHASE II STUDY IN GLIOBLASTOMA AT ESMO 2022-09-09 06:00
YishengBio Received Approvals From Philippines and UAE For Phase 2 / 3 Clinical Trials of PIKA Recombinant COVID-19 vaccine 2022-09-08 21:33
Nutromics raises US$14 million for its ground-breaking wearable diagnostic platform 2022-09-08 20:54
ONE DRUG FOR ONE BUG: DEBIOPHARM TO DISCUSS THE POTENTIAL OF PATHOGEN-SPECIFIC ANTIBIOTICS AT THE 2022 WORLD AMR CONGRESS 2022-09-08 16:41
Cytiva launches BioChallenge in Southeast Asia to support biotech startup development 2022-09-08 15:31
The Outbreak of COVID-19 Unlocked the Demand for Antimicrobial Technologies 2022-09-08 15:12
Innovent's Sintilimab plus Chemotherapy Demonstrated PFS Benefit in Patients with EGFR-mutated Non-Squamous Non-Small Cell Lung Cancer in the Second Interim Analysis Results of the ORIENT-31 Study 2022-09-08 08:05
Sangel Capital Founder Receives Title of China's Top Early-Stage Investor from ChinaVenture Awards 2022-09-07 23:30
NOVAMONT GROUP: NEW CEO FOR OUR 100% OWNED BIOBAG GROUP 2022-09-07 21:07
TikoMed's drug candidate ILB® inhibited infection of human cells by Dengue, Zika and Yellow Fever viruses in vitro, providing further support for its broad spectrum mechanism of action 2022-09-07 14:32
Non-invasive skin immune biomarker test helps predict development of eczema in babies, new study presented at the EADV Congress finds 2022-09-07 06:01
Hummingbird Bioscience to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference 2022-09-06 20:00
Innovent Announces First Participant Dosed in the Higher-dose Cohort of a Phase 2 Clinical Trial of Mazdutide in Chinese Adults with Obesity 2022-09-05 08:00
Aston Sci. Receives IND Approval from U.S. FDA for Phase 2 Clinical Trial of the Therapeutic Cancer Vaccine AST-301 in Patients with HER2 1+/2+ Breast Cancer 2022-09-05 07:00
Antengene Announces XPOVIO® Included for Reimbursement by the PBS in Australia for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma 2022-09-01 08:30
Brii Biosciences Appoints Taiyin Yang to Board of Directors, Strengthening Product Quality Oversight to Support Company Momentum 2022-09-01 07:30
Broncus (02216.HK) announced interim results 2022-08-31 22:04
Mayo Clinic, Hibiscus BioVentures and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator 2022-08-31 21:00
Quris Earns Frost & Sullivan 2022 Europe Technology Innovation Leadership Award for AI-Powered Drug Safety Prediction 2022-08-31 20:00
TikoMed's ILB® mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all neuroinflammation-driven diseases including ALS 2022-08-31 15:29
1 63 64 65 66 67 212